A Repeat Pattern of Founder Events for SARS-CoV-2 Variants in Alaska.

COVID-19 SARS-CoV-2 Variant of Concern (VOC) genomic epidemiology variant

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
13 01 2023
Historique:
received: 02 12 2022
revised: 09 01 2023
accepted: 11 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Alaska is a unique US state because of its large size, geographically disparate population density, and physical distance from the contiguous United States. Here, we describe a pattern of SARS-CoV-2 variant emergence across Alaska reflective of these differences. Using genomic data, we found that in Alaska, the Omicron sublineage BA.2.3 overtook BA.1.1 by the week of 27 February 2022, reaching 48.5% of sequenced cases. On the contrary, in the contiguous United States, BA.1.1 dominated cases for longer, eventually being displaced by BA.2 sublineages other than BA.2.3. BA.2.3 only reached a prevalence of 10.9% in the contiguous United States. Using phylogenetics, we found evidence of potential origins of the two major clades of BA.2.3 in Alaska and with logistic regression estimated how it emerged and spread throughout the state. The combined evidence is suggestive of founder events in Alaska and is reflective of how Alaska's unique dynamics influence the emergence of SARS-CoV-2 variants.

Identifiants

pubmed: 36680262
pii: v15010222
doi: 10.3390/v15010222
pmc: PMC9861170
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103395
Pays : United States

Commentaires et corrections

Type : UpdateOf

Références

Virus Res. 2022 Jul 2;315:198785
pubmed: 35461905
Lancet Respir Med. 2021 Feb;9(2):e20-e21
pubmed: 33417829
Nat Rev Genet. 2021 Dec;22(12):757-773
pubmed: 34535792
Nature. 2022 Apr;604(7906):553-556
pubmed: 35240676
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Arch Virol. 2021 Nov;166(11):3173-3177
pubmed: 34448936
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Natl Sci Rev. 2020 Sep 24;8(1):nwaa246
pubmed: 34676089
Nat Rev Genet. 2022 Sep;23(9):547-562
pubmed: 35459859
Sci Rep. 2022 Nov 30;12(1):20662
pubmed: 36450812
Nat Commun. 2022 Feb 3;13(1):688
pubmed: 35115515
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
J Infect. 2021 Apr;82(4):e27-e28
pubmed: 33383088
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34385165
Cell. 2020 Aug 20;182(4):794-795
pubmed: 32697970
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Nat Rev Genet. 2004 Jan;5(1):52-61
pubmed: 14708016

Auteurs

Tracie J Haan (TJ)

Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK 99775, USA.

Lisa K Smith (LK)

Alaska Division of Public Health, State of Alaska, Fairbanks, AK 99775, USA.

Stephanie DeRonde (S)

Alaska Division of Public Health, State of Alaska, Fairbanks, AK 99775, USA.

Elva House (E)

Alaska Division of Public Health, State of Alaska, Fairbanks, AK 99775, USA.

Jacob Zidek (J)

Alaska Division of Public Health, State of Alaska, Fairbanks, AK 99775, USA.

Diana Puhak (D)

Alaska Division of Public Health, State of Alaska, Fairbanks, AK 99775, USA.

Logan Mullen (L)

Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK 99775, USA.

Matthew Redlinger (M)

Department of Biological Sciences, University of Alaska Anchorage, Anchorage, AK 99508, USA.

Jayme Parker (J)

Alaska Division of Public Health, State of Alaska, Fairbanks, AK 99775, USA.

Brian M Barnes (BM)

Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK 99775, USA.

Jason L Burkhead (JL)

Department of Biological Sciences, University of Alaska Anchorage, Anchorage, AK 99508, USA.

Cindy Knall (C)

WWAMI School of Medical Education, University of Alaska Anchorage, Anchorage, AK 99508, USA.

Eric Bortz (E)

Department of Biological Sciences, University of Alaska Anchorage, Anchorage, AK 99508, USA.
WWAMI School of Medical Education, University of Alaska Anchorage, Anchorage, AK 99508, USA.

Jack Chen (J)

Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK 99775, USA.
Alaska Division of Public Health, State of Alaska, Fairbanks, AK 99775, USA.
Department of Biology and Wildlife, University of Alaska Fairbanks, Fairbanks, AK 99775, USA.

Devin M Drown (DM)

Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK 99775, USA.
Department of Biology and Wildlife, University of Alaska Fairbanks, Fairbanks, AK 99775, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH